CHAD BEEMAN: Open Payments
NPI 1700884830 · PRAIRIEVILLE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,403 in 56 payments from 16 companies in 2025. Trend: 2023 $1,666 · 2024 $2,177 · 2025 $1,403
Food & beverage: $1,403
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $326 |
| Lilly USA, LLC | 9 | $215 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $148 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $117 |
| Amgen Inc. | 3 | $106 |
| AstraZeneca Pharmaceuticals LP | 1 | $102 |
| Novo Nordisk Inc | 1 | $97 |
| Axsome Therapeutics, Inc. | 4 | $84 |
| Abbott Laboratories | 2 | $60 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $47 |
Products named: JARDIANCE, Kerendia, UBRELVY, VRAYLAR, ZEPBOUND, BREZTRI, Ozempic, Auvelity.
Industry payments across LA — which companies pay providers there.
